A systematic review of 11 publications found that research on psychedelics as adjuvants in couples therapy and sex therapy is scarce but highlights four themes: drug effects, protocol characteristics, therapeutic effects and prognosis, and regulatory and training considerations. The authors suggest psychedelics may moderate mood and affective, volitional, and cognitive processes relevant to these therapies. They describe a very favorable prognosis, especially for cases unresponsive to traditional treatment, but emphasize the need for adequate clinical protocol, proper training, and a transdisciplinary team.
Cannabis use enhances many aspects of sexual experience for most users, including increased desire, satisfaction, sensitivity to touch, orgasm intensity, relaxation, and focus, although a minority report mixed or negative effects. In a survey of 216 people with experience using cannabis during sex, 52.3% used cannabis specifically to alter their sexual experience. 38.7% said sex was better, 16.0% said it was better in some ways and worse in others, 24.5% said it was sometimes better, and 4.7% said it was worse. Among 202 participants, 58.9% reported increased desire, 73.8% increased satisfaction, 74.3% increased sensitivity to touch, and 65.7% increased orgasm intensity. Of 199 participants, 69.8% reported better relaxation and 50.
A systematic review of 15 studies found that mindfulness-based therapies improved subjective sexual arousal, desire, satisfaction, and reduced fear linked with sexual activity in women, and improved consistency between perceived and genital arousal. The therapies did not significantly reduce pain during sexual activities. One study showed efficacy for male erectile dysfunction. The authors note that the few available studies have methodological limitations, including small participant numbers, making definite conclusions difficult.